ATE493988T1 - Pyrimidinderivate enthaltendes medikament - Google Patents

Pyrimidinderivate enthaltendes medikament

Info

Publication number
ATE493988T1
ATE493988T1 AT02745972T AT02745972T ATE493988T1 AT E493988 T1 ATE493988 T1 AT E493988T1 AT 02745972 T AT02745972 T AT 02745972T AT 02745972 T AT02745972 T AT 02745972T AT E493988 T1 ATE493988 T1 AT E493988T1
Authority
AT
Austria
Prior art keywords
pyrimidine derivatives
medicine containing
containing pyrimidine
carbon atom
alkyl group
Prior art date
Application number
AT02745972T
Other languages
English (en)
Inventor
Tomiichiro Oda
Shigeko Uryu
Shinya Tokuhiro
Original Assignee
Btg Internat Ltd Company No 2664412
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Internat Ltd Company No 2664412 filed Critical Btg Internat Ltd Company No 2664412
Application granted granted Critical
Publication of ATE493988T1 publication Critical patent/ATE493988T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02745972T 2001-07-13 2002-07-11 Pyrimidinderivate enthaltendes medikament ATE493988T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001213338 2001-07-13
PCT/JP2002/007060 WO2003006024A1 (en) 2001-07-13 2002-07-11 Medicine containing pyrimidine derivative

Publications (1)

Publication Number Publication Date
ATE493988T1 true ATE493988T1 (de) 2011-01-15

Family

ID=19048332

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02745972T ATE493988T1 (de) 2001-07-13 2002-07-11 Pyrimidinderivate enthaltendes medikament

Country Status (10)

Country Link
US (2) US7425559B2 (de)
EP (1) EP1433480B1 (de)
JP (1) JP4398724B2 (de)
AT (1) ATE493988T1 (de)
AU (1) AU2002318802B2 (de)
CA (1) CA2457720C (de)
DE (1) DE60238847D1 (de)
DK (1) DK1433480T3 (de)
ES (1) ES2358888T3 (de)
WO (1) WO2003006024A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1433480T3 (da) * 2001-07-13 2011-04-11 Btg Internat Ltd Company Lægemiddel indeholdende pyrimidin-derivat
GB0917775D0 (en) 2009-10-09 2009-11-25 Btg Int Ltd Novel pharmaceutical compounds
GB0917774D0 (en) * 2009-10-09 2009-11-25 Senexis Ltd Novel pharmaceutical compounds

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51141896A (en) * 1975-05-31 1976-12-07 Sankyo Co Ltd Process for preparing fused ring triazoropyrimidine derivatives
JPS58437B2 (ja) * 1976-03-26 1983-01-06 三共株式会社 縮環トリアゾロピリミジン誘導体
JPS5353697A (en) 1976-10-20 1978-05-16 Sankyo Co Ltd Tricyclic triazolopyrimidine derivatives
JPS5353698A (en) 1976-10-20 1978-05-16 Sankyo Co Ltd Pyrrolotriazolopyrimidine derivatives and their preparation
JPS5368800A (en) 1976-11-30 1978-06-19 Sankyo Co Ltd Cycloalkyl substd. pyrrolotriazolopyrimidine derivatives
JPS5649391A (en) 1979-09-28 1981-05-02 Mochida Pharmaceut Co Ltd Novel bis- 8h-pyrrolo- 3,2-e -s-triazolo- 1,5-a - pyrimidinomethyl amine derivative
JPS5649385A (en) 1979-09-29 1981-05-02 Mochida Pharmaceut Co Ltd Novel s-triazolo- 1,5-a -pyrimidine derivative
JPS5735593A (en) 1980-08-12 1982-02-26 Mochida Pharmaceut Co Ltd Novel pyrolo 3,2-e -s-triazolo 1,5-a pyrimidine derivative
GB2138418B (en) 1982-02-19 1985-12-04 Mochida Pharm Co Ltd Novel s-triazole(1,5-a)pyrimidine derivatives
JPH0276880A (ja) * 1988-06-16 1990-03-16 Sankyo Co Ltd 悪液質改善治療剤
CA1330079C (en) 1988-10-13 1994-06-07 Michihiko Tsujitani Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same
JP3898296B2 (ja) 1996-08-28 2007-03-28 ポーラ化成工業株式会社 ピロロピラゾロピリミジン化合物及びこれを有効成分とする医薬
JPH10218881A (ja) 1997-02-03 1998-08-18 Pola Chem Ind Inc 新規なピロロピラゾロピリミジン誘導体
ATE221886T1 (de) * 1997-09-02 2002-08-15 Bristol Myers Squibb Pharma Co Heterocyclyl-substituierte annellierte pyridine und pyrimidine als antagonisten des corticotropin freisetzenden hormons (crh), verwendbar für die behandlung von cns und stress
NZ506679A (en) 1998-03-27 2002-11-26 Janssen Pharmaceutica Nv HIV inhibiting pyrimidine derivatives
EP0945442A1 (de) 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituierte Pyrimidine Derivate
US6248739B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
TWI271406B (en) * 1999-12-13 2007-01-21 Eisai Co Ltd Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
SE0101523L (sv) 2000-12-29 2002-06-30 Artimplant Ab Linjär polymer
US6693125B2 (en) 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
FR2826011B1 (fr) 2001-06-14 2004-12-10 Oreal Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
DK1433480T3 (da) * 2001-07-13 2011-04-11 Btg Internat Ltd Company Lægemiddel indeholdende pyrimidin-derivat

Also Published As

Publication number Publication date
JP4398724B2 (ja) 2010-01-13
CA2457720C (en) 2010-11-02
EP1433480A1 (de) 2004-06-30
US7425559B2 (en) 2008-09-16
US8288399B2 (en) 2012-10-16
AU2002318802B2 (en) 2007-08-23
EP1433480B1 (de) 2011-01-05
ES2358888T3 (es) 2011-05-16
EP1433480A4 (de) 2005-10-05
JPWO2003006024A1 (ja) 2004-10-28
WO2003006024A1 (en) 2003-01-23
DK1433480T3 (da) 2011-04-11
US20090005402A1 (en) 2009-01-01
AU2002318802A1 (en) 2003-01-29
US20040242605A1 (en) 2004-12-02
DE60238847D1 (de) 2011-02-17
CA2457720A1 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
DK1213296T3 (da) Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf
ATE358484T1 (de) Antidiabetische medikamente
DE60032016D1 (de) Zyklische aminverbindungen als ccr5-rezeptor antagonisten
NO20025035D0 (no) Oksadiazolderivater som har anticancer-effekter
ATE480527T1 (de) Thiadiazolinderivate zur krebsbehandlung
DE60223904D1 (de) Benzylaminanalogen
AU2001269540A1 (en) Serotonin reuptake inhibitors
AU2318600A (en) Chondrongenesis promotors and indolin-2-one derivatives
EP1034783A4 (de) Amidederivaten
ATE493988T1 (de) Pyrimidinderivate enthaltendes medikament
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
ATE319452T1 (de) Arzneimittel gegen essstörungen
DE60325172D1 (de) Verbindungen als semaphorininhibitoren
AU2002214266A1 (en) Carbamate derivatives, process for producing the same and use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties